Orest M. Chemerys
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Orest M. Chemerys has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Dmytro Z. Vorobets
Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
7 shared publications - Roman V. Fafula
Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
7 shared publications - Mykola Z. Vorobets
Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
6 shared publications - Zinoviy D. Vorobets
Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
6 shared publications - Victoria A. Serhiyenko
Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
5 shared publications - Sergii Khimich
National Pirogov Memorial Medical University, Vinnytsya, Ukraine
4 shared publications
Latest Publications
- 28 October 2026
- Published by Publishing House Helvetica (Publications) in Україна. Здоров’я нації
- No. 3,p. 64-72
Neurovegetative and Psychogenic Sexual Health Disorders in Military Personnel with Combat-Related Trauma
Purpose: to determine the characteristics of erectile dysfunction in men with combat trauma compared to the course of erectile dysfunction accompanied by post-traumatic stress disorder. Materials and Methods. The work was based on the results of a survey of 298 men injured as a result of combat operations, using the International Index of Erectile Function-15 questionnaires and the DSM-5 disease classifier for diagnosing post-traumatic stress disorder. The study group was divided into two: men without PTSD (group 1), men with PTSD (group 2). Each group was divided into two subgroups: subgroup 1.1 – men aged 20–39 years without PTSD, subgroup 1.2 – men aged 40–53 years without PTSD, subgroup 2.1 – men aged 20–39 years with PTSD, subgroup 2.2 – men aged 40–53 years with PTSD. Results. It was found that the total score on the IIEF-15 scale in subgroup 1.1 was 20.43, which corresponds to a moderate form of ED, and in subgroup 2.1 this score was 17.21, i.e. it was 1.2 times lower, but also corresponded to a moderate form of ED. In subgroup 1.2 the average score was 17.75, which was 1.3 times higher than in subgroup 2.2. Only in men of subgroup 2.2 who suffered as a result of hostilities and were diagnosed with PTSD the total score was 13.96±0.15, which corresponded to a moderate form of severity. Conclusions. The study demonstrated that veterans with combat-related PTSD demonstrated a significantly higher prevalence of sexual difficulties in all functional domains compared with combatants with combat trauma but without PTSD. The total score on the IIEF-15 was lowest among men aged 40–53 years with combat trauma and comorbid PTSD (subgroup 2.2).
- 28 October 2026
- Published by Publishing House Helvetica (Publications) in Україна. Здоров’я нації
- No. 3,p. 64-72
Neurovegetative and Psychogenic Sexual Health Disorders in Military Personnel with Combat-Related Trauma
Purpose: to determine the characteristics of erectile dysfunction in men with combat trauma compared to the course of erectile dysfunction accompanied by post-traumatic stress disorder. Materials and Methods. The work was based on the results of a survey of 298 men injured as a result of combat operations, using the International Index of Erectile Function-15 questionnaires and the DSM-5 disease classifier for diagnosing post-traumatic stress disorder. The study group was divided into two: men without PTSD (group 1), men with PTSD (group 2). Each group was divided into two subgroups: subgroup 1.1 – men aged 20–39 years without PTSD, subgroup 1.2 – men aged 40–53 years without PTSD, subgroup 2.1 – men aged 20–39 years with PTSD, subgroup 2.2 – men aged 40–53 years with PTSD. Results. It was found that the total score on the IIEF-15 scale in subgroup 1.1 was 20.43, which corresponds to a moderate form of ED, and in subgroup 2.1 this score was 17.21, i.e. it was 1.2 times lower, but also corresponded to a moderate form of ED. In subgroup 1.2 the average score was 17.75, which was 1.3 times higher than in subgroup 2.2. Only in men of subgroup 2.2 who suffered as a result of hostilities and were diagnosed with PTSD the total score was 13.96±0.15, which corresponded to a moderate form of severity. Conclusions. The study demonstrated that veterans with combat-related PTSD demonstrated a significantly higher prevalence of sexual difficulties in all functional domains compared with combatants with combat trauma but without PTSD. The total score on the IIEF-15 was lowest among men aged 40–53 years with combat trauma and comorbid PTSD (subgroup 2.2).
- Open Access
- 17 October 2026
- Published by State Institution of Science "Center of Innovative Healthcare Technologies" State Administrative Department in Clinical and Preventive Medicine
- No. 7,p. 64-73
EFFECTIVENESS OF VARIOUS FORMS OF ERECTILE DYSFUNCTION TREATMENT IN MEN WHO HAVE SUFFERED FROM THE CONSEQUENCES OF COMBAT
Introduction. The long-term consequences of severe injuries sustained by combatants have a significant impact on quality of life and sexual function. Post-traumatic stress disorder, which develops as a result of injuries, is associated with the development of erectile dysfunction, decreased sexual desire, and premature ejaculation.Aim. Analysis of erectile function and quality of life indicators in men of different age groups injured as a result of combat operations before and after the end of treatment.Materials and methods. The study included the results of treatment and a questionnaire survey of 136 men with combat injuries and concomitant sexual dysfunction before and after treatment of the dysfunction. To determine the health-related quality of life, a questionnaire survey was conducted using the SF-36 questionnaire. The second criterion in differentiating the severity of ED was the sum of the scores of the answers to the questions of the International Index of Erectile Function-5 (IIEF-5) questionnaire. According to the form of erectile dysfunction, patients were divided into two groups: Group 1 – patients with psychogenic erectile dysfunction after combat trauma; Group 2 – patients with erectile dysfunction of mixed genesis.Results. In patients of group 1 with a psychogenic form of ED, after treatment, a significant increase in the average score of the domains of general health, role-physical functioning and role-emotional functioning was observed. With a mixed form of ED, as a result of treatment, patients observed significant improvements in role-physical functioning and pain sensation. After comprehensive treatment, in men with psychogenic ED, the average scores of the IIEF-5 questionnaire domain regarding satisfaction with sexual life significantly increased from 2.8 to 5.5 and erectile function from 7.2 to 16.7. In men with a mixed form of erectile dysfunction, erectile function increased the most during treatment, by 7.3 scores.Conclusions. In men, after suffering combat injuries, both psychogenic and mixed forms of erectile dysfunction develop. As a result of the treatment of erectile dysfunction of both psychogenic and mixed forms, general health, role-physical and role-emotional functioning improve. After comprehensive treatment, men with psychogenic erectile dysfunction of both age groups significantly increased their indicators of satisfaction with sexual life and the erectile function domain.
- 17 October 2026
- Published by State Institution of Science "Center of Innovative Healthcare Technologies" State Administrative Department in Clinical and Preventive Medicine
- No. 7,p. 64-73
Open AccessEFFECTIVENESS OF VARIOUS FORMS OF ERECTILE DYSFUNCTION TREATMENT IN MEN WHO HAVE SUFFERED FROM THE CONSEQUENCES OF COMBAT
Introduction. The long-term consequences of severe injuries sustained by combatants have a significant impact on quality of life and sexual function. Post-traumatic stress disorder, which develops as a result of injuries, is associated with the development of erectile dysfunction, decreased sexual desire, and premature ejaculation.Aim. Analysis of erectile function and quality of life indicators in men of different age groups injured as a result of combat operations before and after the end of treatment.Materials and methods. The study included the results of treatment and a questionnaire survey of 136 men with combat injuries and concomitant sexual dysfunction before and after treatment of the dysfunction. To determine the health-related quality of life, a questionnaire survey was conducted using the SF-36 questionnaire. The second criterion in differentiating the severity of ED was the sum of the scores of the answers to the questions of the International Index of Erectile Function-5 (IIEF-5) questionnaire. According to the form of erectile dysfunction, patients were divided into two groups: Group 1 – patients with psychogenic erectile dysfunction after combat trauma; Group 2 – patients with erectile dysfunction of mixed genesis.Results. In patients of group 1 with a psychogenic form of ED, after treatment, a significant increase in the average score of the domains of general health, role-physical functioning and role-emotional functioning was observed. With a mixed form of ED, as a result of treatment, patients observed significant improvements in role-physical functioning and pain sensation. After comprehensive treatment, in men with psychogenic ED, the average scores of the IIEF-5 questionnaire domain regarding satisfaction with sexual life significantly increased from 2.8 to 5.5 and erectile function from 7.2 to 16.7. In men with a mixed form of erectile dysfunction, erectile function increased the most during treatment, by 7.3 scores.Conclusions. In men, after suffering combat injuries, both psychogenic and mixed forms of erectile dysfunction develop. As a result of the treatment of erectile dysfunction of both psychogenic and mixed forms, general health, role-physical and role-emotional functioning improve. After comprehensive treatment, men with psychogenic erectile dysfunction of both age groups significantly increased their indicators of satisfaction with sexual life and the erectile function domain.
- Open Access
- 12 August 2026
- Published by Danylo Halytskyi Lviv National Medical University in Proceeding of the Shevchenko Scientific Society. Medical Sciences
- Vol. 2 (78)
FUNCTIONING OF HOSPITAL PHARMACIES IN UKRAINE
Реферат Доступ до безпечних, ефективних та доступних ліків залишається ключовим компонентом систем охорони здоров'я та важливим фактором, що визначає стан громадського здоров'я та національної безпеки. Нещодавні глобальні та національні виклики, включаючи пандемію COVID-19 та війну, що триває в Україні, виявили слабкі ланки у фармацевтичних ланцюгах постачання, а також підкреслили важливість стійкої інфраструктури охорони здоров'я. У цій статті розглядається роль та потенціал лікарняних аптек як важливого компонента системи фармацевтичного постачання в закладах охорони здоров'я. У дослідженні аналізується нормативно-правова база, що регулює діяльність лікарняних аптек в Україні, та порівнюється з міжнародними підходами, зокрема тими, що прийняті в Європейському Союзі та Сполучених Штатах. Хоча концепція лікарняної аптеки існує в українському законодавстві, на практиці такі структурні підрозділи значною мірою зникли з закладів охорони здоров'я. Водночас міжнародний досвід показує, що лікарняні аптеки відіграють вирішальну роль у закупівлі, виготовленні ліків, зберіганні, розподілі та моніторингу лікарських засобів, а також у забезпеченні раціональної фармакотерапії та безпеки ліків. В аналізі висвітлюються економічні та організаційні переваги відновлення лікарняних аптечних підрозділів, включаючи покращений контроль за розподілом ліків, зниження витрат на лікування завдяки виготовленню ліків в умовах аптек та оптовим закупівлям активних фармацевтичних інгредієнтів, впровадження систем одиничних доз (unit dose) та покращення системи відстеження лікарських засобів в закладі охорони здоров’я. Крім того, лікарняні аптеки можуть слугувати центрами професійної освіти, навчання та клінічних випробувань. Розробка регуляторних механізмів для аптечного виготовлення лікарських засобів, оптових закупівель активних субстанцій та цифровізації процесів обліку лікарських засобів в лікарнях, є перспективним напрямком реформування системи охорони здоров'я. Abstract Access to safe, effective, and affordable medicines remains a key component of healthcare systems and an important determinant of public health and national security. Recent global and national challenges, including the COVID-19 pandemic and the ongoing war in Ukraine, have exposed vulnerabilities in pharmaceutical supply chains while also emphasizing the importance of resilient healthcare infrastructure. This article examines the role and potential of hospital pharmacies as an essential component of the pharmaceutical supply system within healthcare facilities. The study analyzes the regulatory framework governing hospital pharmacies in Ukraine and compares it with the international approaches, particularly those adopted in the European Union and the United States. Although the concepts of hospital pharmacy exist in Ukrainian legislation, in practice such structural units have largely disappeared from healthcare facilities. At the same time, international experience demonstrates that hospital pharmacies play a crucial role in procurement, compounding, storage, distribution, and monitoring of medicines, as well as in ensuring rational pharmacotherapy and drug safety. The analysis highlights the economic and organizational advantages of restoring hospital pharmacy units, including improved control over drug distribution, reduction of treatment costs through pharmacy compounding and bulk procurement of active pharmaceutical ingredients, implementation of unit-dose systems, and improved drug traceability. In addition, hospital pharmacies can serve as centers for professional education, training and clinical trials. The development of regulatory mechanisms supporting pharmacy compounding, bulk procurement of pharmaceutical substances, and digitalization of medication management processes is considered a promising direction for healthcare system reform.
- 12 August 2026
- Published by Danylo Halytskyi Lviv National Medical University in Proceeding of the Shevchenko Scientific Society. Medical Sciences
- Vol. 2 (78)
Open AccessFUNCTIONING OF HOSPITAL PHARMACIES IN UKRAINE
Реферат Доступ до безпечних, ефективних та доступних ліків залишається ключовим компонентом систем охорони здоров'я та важливим фактором, що визначає стан громадського здоров'я та національної безпеки. Нещодавні глобальні та національні виклики, включаючи пандемію COVID-19 та війну, що триває в Україні, виявили слабкі ланки у фармацевтичних ланцюгах постачання, а також підкреслили важливість стійкої інфраструктури охорони здоров'я. У цій статті розглядається роль та потенціал лікарняних аптек як важливого компонента системи фармацевтичного постачання в закладах охорони здоров'я. У дослідженні аналізується нормативно-правова база, що регулює діяльність лікарняних аптек в Україні, та порівнюється з міжнародними підходами, зокрема тими, що прийняті в Європейському Союзі та Сполучених Штатах. Хоча концепція лікарняної аптеки існує в українському законодавстві, на практиці такі структурні підрозділи значною мірою зникли з закладів охорони здоров'я. Водночас міжнародний досвід показує, що лікарняні аптеки відіграють вирішальну роль у закупівлі, виготовленні ліків, зберіганні, розподілі та моніторингу лікарських засобів, а також у забезпеченні раціональної фармакотерапії та безпеки ліків. В аналізі висвітлюються економічні та організаційні переваги відновлення лікарняних аптечних підрозділів, включаючи покращений контроль за розподілом ліків, зниження витрат на лікування завдяки виготовленню ліків в умовах аптек та оптовим закупівлям активних фармацевтичних інгредієнтів, впровадження систем одиничних доз (unit dose) та покращення системи відстеження лікарських засобів в закладі охорони здоров’я. Крім того, лікарняні аптеки можуть слугувати центрами професійної освіти, навчання та клінічних випробувань. Розробка регуляторних механізмів для аптечного виготовлення лікарських засобів, оптових закупівель активних субстанцій та цифровізації процесів обліку лікарських засобів в лікарнях, є перспективним напрямком реформування системи охорони здоров'я. Abstract Access to safe, effective, and affordable medicines remains a key component of healthcare systems and an important determinant of public health and national security. Recent global and national challenges, including the COVID-19 pandemic and the ongoing war in Ukraine, have exposed vulnerabilities in pharmaceutical supply chains while also emphasizing the importance of resilient healthcare infrastructure. This article examines the role and potential of hospital pharmacies as an essential component of the pharmaceutical supply system within healthcare facilities. The study analyzes the regulatory framework governing hospital pharmacies in Ukraine and compares it with the international approaches, particularly those adopted in the European Union and the United States. Although the concepts of hospital pharmacy exist in Ukrainian legislation, in practice such structural units have largely disappeared from healthcare facilities. At the same time, international experience demonstrates that hospital pharmacies play a crucial role in procurement, compounding, storage, distribution, and monitoring of medicines, as well as in ensuring rational pharmacotherapy and drug safety. The analysis highlights the economic and organizational advantages of restoring hospital pharmacy units, including improved control over drug distribution, reduction of treatment costs through pharmacy compounding and bulk procurement of active pharmaceutical ingredients, implementation of unit-dose systems, and improved drug traceability. In addition, hospital pharmacies can serve as centers for professional education, training and clinical trials. The development of regulatory mechanisms supporting pharmacy compounding, bulk procurement of pharmaceutical substances, and digitalization of medication management processes is considered a promising direction for healthcare system reform.
- Open Access
- 19 June 2026
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 93 (3) , 3-9
Diagnosis and Surgical Treatment of Biliodigestive Fistulas: An Analysis of Our Clinical Experience
Objective. To evaluate the possibilities of preoperative diagnosis and the results of surgical treatment of biliodigestive fistulas based on an analysis of our own clinical experience. Materials and Methods. We analyzed the results of examination and treatment of 52 patients with gallstone disease complicated by biliodigestive fistulas between 1994 and 2024. Laboratory tests, ultrasound, computed tomography (as needed), endoscopic, and radiological methods were used. All patients underwent surgery. Results. Cholecystoduodenal fistulas were most commonly detected (57.7%). The sensitivity of ultrasound in diagnosing biliodigestive fistulas was 71.2%, computed tomography–83.3%, and endoscopic methods–82.8%. The primary treatment method involved fistula division, cholecystectomy, and restoration of bile duct patency. Postoperative complications occurred in 7.8% of patients. The mortality rate was 1.9%. Conclusions. With a comprehensive approach to diagnosis and individualized surgical management, treatment outcomes for patients with biliodigestive fistulas are acceptable.
- 19 June 2026
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 93 (3) , 3-9
Open AccessDiagnosis and Surgical Treatment of Biliodigestive Fistulas: An Analysis of Our Clinical Experience
Objective. To evaluate the possibilities of preoperative diagnosis and the results of surgical treatment of biliodigestive fistulas based on an analysis of our own clinical experience. Materials and Methods. We analyzed the results of examination and treatment of 52 patients with gallstone disease complicated by biliodigestive fistulas between 1994 and 2024. Laboratory tests, ultrasound, computed tomography (as needed), endoscopic, and radiological methods were used. All patients underwent surgery. Results. Cholecystoduodenal fistulas were most commonly detected (57.7%). The sensitivity of ultrasound in diagnosing biliodigestive fistulas was 71.2%, computed tomography–83.3%, and endoscopic methods–82.8%. The primary treatment method involved fistula division, cholecystectomy, and restoration of bile duct patency. Postoperative complications occurred in 7.8% of patients. The mortality rate was 1.9%. Conclusions. With a comprehensive approach to diagnosis and individualized surgical management, treatment outcomes for patients with biliodigestive fistulas are acceptable.
- 5 June 2026
- Published by Danylo Halytskyi Lviv National Medical University in Proceeding of the Shevchenko Scientific Society. Medical Sciences
- Vol. 1 (78)
BORYS ZIMENKOVSKY (SEPTEMBER 26, 1940 – APRIL 3, 2026)
On April 3, 2026, at the age of 86, the distinguished scholar, scientist, and educator Borys Zimenkovsky passed away. We have lost the long-time rector of the Danylo Halytsky Lviv National Medical University (1998–2023), Borys Zimenkovsky, an academician of the National Academy of Medical Sciences of Ukraine, Doctor of Pharmaceutical Sciences, professor, Honored Worker of Higher Education of Ukraine, laureate of the State Prize of Ukraine in Science and Technology, Honored Professor of Danylo Halytsky Lviv National Medical University, and full member of the Shevchenko Scientific Society. Borys Zimenkovsky was born on September 26, 1940, in the Ternopil region. His entire life has been inextricably linked to the Danylo Halytsky Lviv National Medical University — its formation, development, and rise to a leading position among medical educational institutions. He first set foot on the campus of what was then the Lviv State Medical Institute in 1958, when he enrolled in the Faculty of Pharmacy. Since then, for 68 years, Borys Zimenkovsky's life and professional career have been inextricably linked to this institution. His development as a scientist and educator also took place here: from postgraduate student (1963–1966), assistant (1964–1972), associate professor (1972–1978), to professor and chair of the Department of Pharmaceutical, Organic, and Bioorganic Chemistry (1978–2016). Thanks to his exceptional leadership and organizational talent, he made a significant contribution to the development of our university: he served as dean of the Faculty of Pharmacy (1972–1979); for nearly twenty years (1979–1998), he worked fruitfully as vice rector for academic affairs, introducing the latest technologies into the process of training specialists; For 25 years (1998–2023), he served as rector of the university, preserving and enhancing the finest academic traditions and high standards of Ukraine’s oldest medical university. From July 2023, Academician B. Zimenkovsky served as an advisor to Rector Prof. O. Chemerys. Borys Zimenkovsky always cared deeply about the University, its status, prestige, and recognition. He strove to ensure that the achievements and contributions of the university community were duly honored and recognized. To this end, he made considerable efforts and achieved his goal: on October 21, 1998, the university was named after Danylo Halytskyi. On August 21, 2003, in recognition of its significant contribution to the development of national education and science, as well as its national and international recognition, the Danylo Halytskyi Lviv State Medical University was granted the status of a National Medical University. His priorities included high-quality training of young professionals and academic staff, the advancement of scientific research, and modernization of the University's material and technical infrastructure. During his time in leadership positions, he succeeded in laying the organizational and methodological foundation for the university’s strategic and program-oriented development; thanks to his efforts, the University continued to grow and develop. The construction of the university’s own Dental Medical Center and the integration of the regional dental clinic into Lviv National Medical University — all of this was his doing, the result of his work. He also initiated the idea of transforming the Lviv Railway Hospital into the University Hospital. He knew how to think ahead and act strategically. B. Zimenkovsky is a renowned scientist in the fields of pharmaceutical, organic, and medical chemistry. He made a significant contribution to the development of the chemistry of hetero- and macroheterocyclic compounds, the study of the relationship between structure and action, the search for new biologically active compounds, and the creation of a number of medicinal drugs; he initiated pioneering work in Ukraine on virtual synthesis using methods of quantum chemistry. Under the leadership of B. Zimenkovsky, a comprehensive library of thiazolidine and thiazane derivatives was established; modern research methods—such as QSAR studies, molecular docking, and virtual synthesis—are widely employed; lead structures are identified, and the rational design of potential drugs is underway. Professor B. Zimenkovsky founded his own scientific school dedicated to the creation of new biologically active compounds and pharmaceuticals; he has supervised 15 PhD candidates and 7 doctoral dissertations. His scientific school is carried on by Professors Iryna Drapak and Roman Lesyk. B. Zimenkovsky’s substantial scientific output includes over 1,115 scientific and educational works, including 3 monographs, 17 books, 20 manuals and textbooks, 948 articles, 73 certificates of authorship for inventions, 94 patents, and he is a co-author of 5 pharmaceutical preparations (flureniside, lithium hydroglyutamate, nootril, thiotriazoline, and thiocetam). As a highly qualified scientific expert, B. Zimenkovsky served for 25 years as chair of the Academic Council and as a member of the Scientific Medical Council of the Ministry of Health of Ukraine; a member of the Expert Council of the Higher Attestation Commission, and chairman of the specialized doctoral Academic Council at the Danylo Halytsky Lviv National Medical University in the following specialties: 15.00.01 — drug technology, pharmaceutical management, and forensic pharmacy; 15.00.02 — pharmaceutical chemistry and pharmacognosy. For his scientific contributions and significant achievements in the field of synthesizing physiologically active substances and developing new medicinal products, Academician Borys Zimenkovsky has received high recognition in scientific circles both in Ukraine and abroad. He was a laureate of the State Prize of Ukraine in Science and Technology (2000), president of the Galician Pharmaceutical...
- 5 June 2026
- Published by Danylo Halytskyi Lviv National Medical University in Proceeding of the Shevchenko Scientific Society. Medical Sciences
- Vol. 1 (78)
BORYS ZIMENKOVSKY (SEPTEMBER 26, 1940 – APRIL 3, 2026)
On April 3, 2026, at the age of 86, the distinguished scholar, scientist, and educator Borys Zimenkovsky passed away. We have lost the long-time rector of the Danylo Halytsky Lviv National Medical University (1998–2023), Borys Zimenkovsky, an academician of the National Academy of Medical Sciences of Ukraine, Doctor of Pharmaceutical Sciences, professor, Honored Worker of Higher Education of Ukraine, laureate of the State Prize of Ukraine in Science and Technology, Honored Professor of Danylo Halytsky Lviv National Medical University, and full member of the Shevchenko Scientific Society. Borys Zimenkovsky was born on September 26, 1940, in the Ternopil region. His entire life has been inextricably linked to the Danylo Halytsky Lviv National Medical University — its formation, development, and rise to a leading position among medical educational institutions. He first set foot on the campus of what was then the Lviv State Medical Institute in 1958, when he enrolled in the Faculty of Pharmacy. Since then, for 68 years, Borys Zimenkovsky's life and professional career have been inextricably linked to this institution. His development as a scientist and educator also took place here: from postgraduate student (1963–1966), assistant (1964–1972), associate professor (1972–1978), to professor and chair of the Department of Pharmaceutical, Organic, and Bioorganic Chemistry (1978–2016). Thanks to his exceptional leadership and organizational talent, he made a significant contribution to the development of our university: he served as dean of the Faculty of Pharmacy (1972–1979); for nearly twenty years (1979–1998), he worked fruitfully as vice rector for academic affairs, introducing the latest technologies into the process of training specialists; For 25 years (1998–2023), he served as rector of the university, preserving and enhancing the finest academic traditions and high standards of Ukraine’s oldest medical university. From July 2023, Academician B. Zimenkovsky served as an advisor to Rector Prof. O. Chemerys. Borys Zimenkovsky always cared deeply about the University, its status, prestige, and recognition. He strove to ensure that the achievements and contributions of the university community were duly honored and recognized. To this end, he made considerable efforts and achieved his goal: on October 21, 1998, the university was named after Danylo Halytskyi. On August 21, 2003, in recognition of its significant contribution to the development of national education and science, as well as its national and international recognition, the Danylo Halytskyi Lviv State Medical University was granted the status of a National Medical University. His priorities included high-quality training of young professionals and academic staff, the advancement of scientific research, and modernization of the University's material and technical infrastructure. During his time in leadership positions, he succeeded in laying the organizational and methodological foundation for the university’s strategic and program-oriented development; thanks to his efforts, the University continued to grow and develop. The construction of the university’s own Dental Medical Center and the integration of the regional dental clinic into Lviv National Medical University — all of this was his doing, the result of his work. He also initiated the idea of transforming the Lviv Railway Hospital into the University Hospital. He knew how to think ahead and act strategically. B. Zimenkovsky is a renowned scientist in the fields of pharmaceutical, organic, and medical chemistry. He made a significant contribution to the development of the chemistry of hetero- and macroheterocyclic compounds, the study of the relationship between structure and action, the search for new biologically active compounds, and the creation of a number of medicinal drugs; he initiated pioneering work in Ukraine on virtual synthesis using methods of quantum chemistry. Under the leadership of B. Zimenkovsky, a comprehensive library of thiazolidine and thiazane derivatives was established; modern research methods—such as QSAR studies, molecular docking, and virtual synthesis—are widely employed; lead structures are identified, and the rational design of potential drugs is underway. Professor B. Zimenkovsky founded his own scientific school dedicated to the creation of new biologically active compounds and pharmaceuticals; he has supervised 15 PhD candidates and 7 doctoral dissertations. His scientific school is carried on by Professors Iryna Drapak and Roman Lesyk. B. Zimenkovsky’s substantial scientific output includes over 1,115 scientific and educational works, including 3 monographs, 17 books, 20 manuals and textbooks, 948 articles, 73 certificates of authorship for inventions, 94 patents, and he is a co-author of 5 pharmaceutical preparations (flureniside, lithium hydroglyutamate, nootril, thiotriazoline, and thiocetam). As a highly qualified scientific expert, B. Zimenkovsky served for 25 years as chair of the Academic Council and as a member of the Scientific Medical Council of the Ministry of Health of Ukraine; a member of the Expert Council of the Higher Attestation Commission, and chairman of the specialized doctoral Academic Council at the Danylo Halytsky Lviv National Medical University in the following specialties: 15.00.01 — drug technology, pharmaceutical management, and forensic pharmacy; 15.00.02 — pharmaceutical chemistry and pharmacognosy. For his scientific contributions and significant achievements in the field of synthesizing physiologically active substances and developing new medicinal products, Academician Borys Zimenkovsky has received high recognition in scientific circles both in Ukraine and abroad. He was a laureate of the State Prize of Ukraine in Science and Technology (2000), president of the Galician Pharmaceutical...
- 5 June 2026
- Published by Danylo Halytskyi Lviv National Medical University in Proceeding of the Shevchenko Scientific Society. Medical Sciences
- Vol. 1 (78)
WAR AND HEALTHCARE SYSTEMS: UKRAINIAN AND GLOBAL EXPERIENCES
Background: The full-scale Russian invasion of Ukraine, like any military aggression, creates obstacles to preventive and therapeutic measures, reducing the ability of the healthcare system to provide timely and high-quality care to patients with various pathologies and conditions. Objective: The study was conducted to analyze global and local experiences of the impact of hostilities and war on the operational functioning of healthcare systems. Materials and Methods: In conducting this study, a bibliosemantic method was used, involving a search for relevant scientific sources across the following databases: PubMed, Cochrane Library, BMJ Group, and the Vernadsky National Library of Ukraine. The collected information was processed using PEST analysis in compliance with the principle of a systematic approach. Results: According to the PEST analysis, the impact of war on healthcare institutions and the public health system revealed several negative aspects. Politically, these include the destruction of medical infrastructure, the occupation of territories, and an increased burden on management. Economically, the system faces facility damage, rising costs for trauma and mental health, and reduced state resources due to defense budget reorientation. Socially, there is an increasing level of population trauma, massive internal displacement creating uneven burdens on facilities, and reduced access to preventive care. Technologically, the war caused infrastructure destruction, utility interruptions, and limited high-tech assistance in frontline regions. Conclusions: The results of the PEST analysis indicate that while the war creates significant political, economic, social, and technological challenges for the Ukrainian healthcare system, it simultaneously stimulates transformation through flexible management, digitalization, and international integration. To build a system adapted to war conditions, it is vital to develop and implement new models that strengthen institutional resilience against crises.
- 5 June 2026
- Published by Danylo Halytskyi Lviv National Medical University in Proceeding of the Shevchenko Scientific Society. Medical Sciences
- Vol. 1 (78)
WAR AND HEALTHCARE SYSTEMS: UKRAINIAN AND GLOBAL EXPERIENCES
Background: The full-scale Russian invasion of Ukraine, like any military aggression, creates obstacles to preventive and therapeutic measures, reducing the ability of the healthcare system to provide timely and high-quality care to patients with various pathologies and conditions. Objective: The study was conducted to analyze global and local experiences of the impact of hostilities and war on the operational functioning of healthcare systems. Materials and Methods: In conducting this study, a bibliosemantic method was used, involving a search for relevant scientific sources across the following databases: PubMed, Cochrane Library, BMJ Group, and the Vernadsky National Library of Ukraine. The collected information was processed using PEST analysis in compliance with the principle of a systematic approach. Results: According to the PEST analysis, the impact of war on healthcare institutions and the public health system revealed several negative aspects. Politically, these include the destruction of medical infrastructure, the occupation of territories, and an increased burden on management. Economically, the system faces facility damage, rising costs for trauma and mental health, and reduced state resources due to defense budget reorientation. Socially, there is an increasing level of population trauma, massive internal displacement creating uneven burdens on facilities, and reduced access to preventive care. Technologically, the war caused infrastructure destruction, utility interruptions, and limited high-tech assistance in frontline regions. Conclusions: The results of the PEST analysis indicate that while the war creates significant political, economic, social, and technological challenges for the Ukrainian healthcare system, it simultaneously stimulates transformation through flexible management, digitalization, and international integration. To build a system adapted to war conditions, it is vital to develop and implement new models that strengthen institutional resilience against crises.
- Open Access
- 28 May 2026
- Published by Publishing House Helvetica (Publications) in Public Health Journal
- No. 1,p. 166-179
РАНДОМІЗОВАНІ КОНТРОЛЬОВАНІ КЛІНІЧНІ ДОСЛІДЖЕННЯ: КОНЦЕПТУАЛЬНІ ОСНОВИ ТА НАУКОВО-МЕТОДОЛОГІЧНІ ПІДХОДИ ДО ТРАНСЛЯЦІЇ ДОКАЗІВ У КЛІНІЧНУ ПРАКТИКУ
Актуальність. Доказова медицина що базується на результатах рандомізованих контрольованих клінічних дослідженнях - як «золотому стандарті», потребує належного розуміння лікарями як теоретичних основ до їх інтерпретації, так і науково- методологічних підходів до їх імплементації результатів у клінічну практику.Мета дослідження – теоретично обґрунтувати концептуальні зсади рандомізованих клінічних досліджень як «золотого стандарту» доказової медицини та узагальнити науково-методологічні підходи до імплементації їх результатів у клінічну практику лікаря в умовах трансформації системи охорони здоров’я України.Матеріали та методи. Виконане одномоментне, оглядове, суцільне науково-теоретичне та прикладне дослідження, спрямоване на досягнення мети та завдань роботи. Матеріалами слугували сучасні наукові публікації, огляди, методичні рекомендації та дослідження (2019–2024 рр.), що відображають дизайн і результати РКД, а також підходи до їх інтеграції в клінічну практику та управлінські рішення.Методологічну основу становили системний аналіз, порівняльний метод, синтез і узагальнення, структурно-логічний та системно-структурний аналіз, а також дедуктивний підхід із контент-аналізом на основі принципів системності, що відповідають галузі знань «I Охорона здоров’я та соціальне забезпечення»Результати дослідження. Результати узагальнення наукових джерел підтвердили, що рандомізовані клінічні дослідження є «золотим стандартом» доказової медицини, оскільки забезпечують найвищий рівень достовірності оцінки ефективності та безпеки медичних втручань і формують основу клінічних рекомендацій. Встановлено, що застосування моделі PICO для формулювання клінічного запитання підвищує чіткість визначення пацієнта, втручання, порівняння та результату, що оптимізує подальший пошук і аналіз доказів. Доведено, що використання стандартизованих алгоритмів пошуку в електронних базах даних забезпечує відбір високоякісних досліджень, підвищує точність результатів і зменшує вплив суб’єктивності. Окремо відзначено, що імплементація отриманих доказів у клінічну практику є ключовим чинником підвищення якості медичної допомоги та стандартизації лікувально-діагностичних рішень.Висновки. Доказова медицина виступає ключовою методологічною основою сучасної клінічної практики, що інтегрує результати досліджень найвищого рівня доказовості з клінічним досвідом лікаря та індивідуальними особливостями пацієнта, забезпечуючи оптимізацію лікувально-діагностичних стратегій і підвищення ефективності вторинної профілактики захворювань. Доведено, що впровадження алгоритмізованого підходу до пошуку, критичної оцінки та узагальнення наукових доказів у клінічну практику сприяє підвищенню якості медичних рішень, їх наукової обґрунтованості, відтворюваності та стандартизації.
- 28 May 2026
- Published by Publishing House Helvetica (Publications) in Public Health Journal
- No. 1,p. 166-179
Open AccessРАНДОМІЗОВАНІ КОНТРОЛЬОВАНІ КЛІНІЧНІ ДОСЛІДЖЕННЯ: КОНЦЕПТУАЛЬНІ ОСНОВИ ТА НАУКОВО-МЕТОДОЛОГІЧНІ ПІДХОДИ ДО ТРАНСЛЯЦІЇ ДОКАЗІВ У КЛІНІЧНУ ПРАКТИКУ
Актуальність. Доказова медицина що базується на результатах рандомізованих контрольованих клінічних дослідженнях - як «золотому стандарті», потребує належного розуміння лікарями як теоретичних основ до їх інтерпретації, так і науково- методологічних підходів до їх імплементації результатів у клінічну практику.Мета дослідження – теоретично обґрунтувати концептуальні зсади рандомізованих клінічних досліджень як «золотого стандарту» доказової медицини та узагальнити науково-методологічні підходи до імплементації їх результатів у клінічну практику лікаря в умовах трансформації системи охорони здоров’я України.Матеріали та методи. Виконане одномоментне, оглядове, суцільне науково-теоретичне та прикладне дослідження, спрямоване на досягнення мети та завдань роботи. Матеріалами слугували сучасні наукові публікації, огляди, методичні рекомендації та дослідження (2019–2024 рр.), що відображають дизайн і результати РКД, а також підходи до їх інтеграції в клінічну практику та управлінські рішення.Методологічну основу становили системний аналіз, порівняльний метод, синтез і узагальнення, структурно-логічний та системно-структурний аналіз, а також дедуктивний підхід із контент-аналізом на основі принципів системності, що відповідають галузі знань «I Охорона здоров’я та соціальне забезпечення»Результати дослідження. Результати узагальнення наукових джерел підтвердили, що рандомізовані клінічні дослідження є «золотим стандартом» доказової медицини, оскільки забезпечують найвищий рівень достовірності оцінки ефективності та безпеки медичних втручань і формують основу клінічних рекомендацій. Встановлено, що застосування моделі PICO для формулювання клінічного запитання підвищує чіткість визначення пацієнта, втручання, порівняння та результату, що оптимізує подальший пошук і аналіз доказів. Доведено, що використання стандартизованих алгоритмів пошуку в електронних базах даних забезпечує відбір високоякісних досліджень, підвищує точність результатів і зменшує вплив суб’єктивності. Окремо відзначено, що імплементація отриманих доказів у клінічну практику є ключовим чинником підвищення якості медичної допомоги та стандартизації лікувально-діагностичних рішень.Висновки. Доказова медицина виступає ключовою методологічною основою сучасної клінічної практики, що інтегрує результати досліджень найвищого рівня доказовості з клінічним досвідом лікаря та індивідуальними особливостями пацієнта, забезпечуючи оптимізацію лікувально-діагностичних стратегій і підвищення ефективності вторинної профілактики захворювань. Доведено, що впровадження алгоритмізованого підходу до пошуку, критичної оцінки та узагальнення наукових доказів у клінічну практику сприяє підвищенню якості медичних рішень, їх наукової обґрунтованості, відтворюваності та стандартизації.
- Open Access
- 31 March 2026
- Published by Professional Event, LLC in Health of Man
- No. 1,p. 6-12
Treatment for Mixed Genesis Erectile Dysfunction Accompanied by Chronic Pelvic Pain or Premature Ejaculation in Men with Combat Injury
Participants in hostilities often face long-term effects of severe injuries, which can markedly impair both quality of life and sexual function. The objective: to assess the effectiveness of treatment for mixed genesis erectile dysfunction (ED) accompanied by chronic pelvic pain (CPP) or premature ejaculation (PE) in men with combat injury. Materials and methods. The examination of 60 men aged 20–53, participants in hostilities, with sexual dysfunction was performed. The main complaints were ED accompanied by CPP or PE. According to the form of ED, patients were divided into groups: Group 1 included patients with ED of mixed etiology associated with CPP (n = 32); Group 2 consisted of patients with ED of mixed origin accompanied by PE (n = 28). Results. It has been demonstrated that lifestyle modification is an effective treatment method for ED, which is accompanied by CPP in men with a combat injury. 62.5% of patients have a significant improvement in erectile function, and 31.2% have a slight improvement. The efficacy of treatment of ED associated with PE is linked to serotonin reuptake inhibitors (SRIs), confirming the key role of the neurotransmitter serotonin in the modulation of ejaculation. Significant improvement in this group was observed in 53.6% of patients, and insignificant in 39.3%. Conclusions. The most effective method of treatment is lifestyle modification for patients injured as a result of hostilities, with ED of mixed genesis, accompanied by the leading syndrome of CPP. This group demonstrated an improvement in International Index of Erectile Function (IIEF)-5 score from 13.5 ± 2.3 to 21.6 ± 2.1 (p < 0.05). Serotonin is a key neurotransmitter involved in the regulation of ejaculation in patients with ED and coexisting PE, as treatment with SRIs prolongs intravaginal ejaculatory latency. This group also demonstrated an improvement in IIEF-5 score from 13.8 ± 2.1 to 22.0 ± 1.9 (p < 0.05).
- 31 March 2026
- Published by Professional Event, LLC in Health of Man
- No. 1,p. 6-12
Open AccessTreatment for Mixed Genesis Erectile Dysfunction Accompanied by Chronic Pelvic Pain or Premature Ejaculation in Men with Combat Injury
Participants in hostilities often face long-term effects of severe injuries, which can markedly impair both quality of life and sexual function. The objective: to assess the effectiveness of treatment for mixed genesis erectile dysfunction (ED) accompanied by chronic pelvic pain (CPP) or premature ejaculation (PE) in men with combat injury. Materials and methods. The examination of 60 men aged 20–53, participants in hostilities, with sexual dysfunction was performed. The main complaints were ED accompanied by CPP or PE. According to the form of ED, patients were divided into groups: Group 1 included patients with ED of mixed etiology associated with CPP (n = 32); Group 2 consisted of patients with ED of mixed origin accompanied by PE (n = 28). Results. It has been demonstrated that lifestyle modification is an effective treatment method for ED, which is accompanied by CPP in men with a combat injury. 62.5% of patients have a significant improvement in erectile function, and 31.2% have a slight improvement. The efficacy of treatment of ED associated with PE is linked to serotonin reuptake inhibitors (SRIs), confirming the key role of the neurotransmitter serotonin in the modulation of ejaculation. Significant improvement in this group was observed in 53.6% of patients, and insignificant in 39.3%. Conclusions. The most effective method of treatment is lifestyle modification for patients injured as a result of hostilities, with ED of mixed genesis, accompanied by the leading syndrome of CPP. This group demonstrated an improvement in International Index of Erectile Function (IIEF)-5 score from 13.5 ± 2.3 to 21.6 ± 2.1 (p < 0.05). Serotonin is a key neurotransmitter involved in the regulation of ejaculation in patients with ED and coexisting PE, as treatment with SRIs prolongs intravaginal ejaculatory latency. This group also demonstrated an improvement in IIEF-5 score from 13.8 ± 2.1 to 22.0 ± 1.9 (p < 0.05).
- Open Access
- 31 March 2026
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 31 (1) , 80-89
Comparative effect of dapoxetine and venlafaxine in the treatment of premature ejaculation in men injured as a result of hostilities
Premature ejaculation is one of the most common male sexual disorders and occurs with a frequency of 21-33% in various populations. The etiology of premature ejaculation is practically not established, although it is a fairly common type of sexual dysfunction. According to various data, sexual dysfunction occurs in 49.1-80% veterans of combat-actions with post-traumatic stress disorder. Premature ejaculation can interfere with sexual satisfaction, leading to a reduced quality of life for men and their partners. It has been shown that serotonin reuptake inhibitors may be the drugs of choice in the treatment of premature ejaculation. The aim of the work was to improve methods of treating sexual dysfunction accompanied by premature ejaculation in men injured as a result of hostilities. 56 men injured as a result of hostilities with sexual dysfunction and complaints of premature ejaculation were examined. Patients were divided into two groups depending on the selected selective serotonin reuptake inhibitors – venlafaxine (n=24) and dapoxetine (n=32) which they had been receiving for at least 1.5 months. After treatment with both serotonin reuptake inhibitors, reactive and personality anxiety symptoms objectively decreased, as assessed by the Spielberger-Hanan scale. Treatment with venlafaxine and paroxetine resulted in a significant reduction in depressive symptoms in men with premature ejaculation. They turned out to be relatively balanced drugs with satisfactory efficacy and relatively few side effects. However, venlafaxine, compared to dapoxetine, produced 2.1 times fewer side effects and 20% fewer relapses. The average duration of sexual intercourse after treatment with both drugs positively correlated with the overall improvement of sexual function according to the IIEF-5 scale (r=0.70; p<0.05 for the first group; r=0.85; p<0.05 for the second group). An inverse correlation was found between the average duration of sexual intercourse and the score of anxiety symptoms on the Spielberger-Hanin scale in patients of both study groups (r= -0.69; p<0.05 for the first group; r= -0.68; p<0.05 for the second group). Although dapoxetine is considered the “gold standard” among serotonin reuptake inhibitors for the treatment of premature ejaculation, the drug is used by the patient only on demand, and other drugs in this group, which are antidepressants, may have a more positive effect on patients with depression and concomitant premature ejaculation, who have suffered as a result of hostilities. The study demonstrates that the neurotransmitter serotonin plays a key role in the modulation of ejaculation, as the use of its reuptake inhibitors, in particular dapoxetine and venlafaxine, contributes to an increase in intravaginal latency time to ejaculation.
- 31 March 2026
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 31 (1) , 80-89
Open AccessComparative effect of dapoxetine and venlafaxine in the treatment of premature ejaculation in men injured as a result of hostilities
Premature ejaculation is one of the most common male sexual disorders and occurs with a frequency of 21-33% in various populations. The etiology of premature ejaculation is practically not established, although it is a fairly common type of sexual dysfunction. According to various data, sexual dysfunction occurs in 49.1-80% veterans of combat-actions with post-traumatic stress disorder. Premature ejaculation can interfere with sexual satisfaction, leading to a reduced quality of life for men and their partners. It has been shown that serotonin reuptake inhibitors may be the drugs of choice in the treatment of premature ejaculation. The aim of the work was to improve methods of treating sexual dysfunction accompanied by premature ejaculation in men injured as a result of hostilities. 56 men injured as a result of hostilities with sexual dysfunction and complaints of premature ejaculation were examined. Patients were divided into two groups depending on the selected selective serotonin reuptake inhibitors – venlafaxine (n=24) and dapoxetine (n=32) which they had been receiving for at least 1.5 months. After treatment with both serotonin reuptake inhibitors, reactive and personality anxiety symptoms objectively decreased, as assessed by the Spielberger-Hanan scale. Treatment with venlafaxine and paroxetine resulted in a significant reduction in depressive symptoms in men with premature ejaculation. They turned out to be relatively balanced drugs with satisfactory efficacy and relatively few side effects. However, venlafaxine, compared to dapoxetine, produced 2.1 times fewer side effects and 20% fewer relapses. The average duration of sexual intercourse after treatment with both drugs positively correlated with the overall improvement of sexual function according to the IIEF-5 scale (r=0.70; p<0.05 for the first group; r=0.85; p<0.05 for the second group). An inverse correlation was found between the average duration of sexual intercourse and the score of anxiety symptoms on the Spielberger-Hanin scale in patients of both study groups (r= -0.69; p<0.05 for the first group; r= -0.68; p<0.05 for the second group). Although dapoxetine is considered the “gold standard” among serotonin reuptake inhibitors for the treatment of premature ejaculation, the drug is used by the patient only on demand, and other drugs in this group, which are antidepressants, may have a more positive effect on patients with depression and concomitant premature ejaculation, who have suffered as a result of hostilities. The study demonstrates that the neurotransmitter serotonin plays a key role in the modulation of ejaculation, as the use of its reuptake inhibitors, in particular dapoxetine and venlafaxine, contributes to an increase in intravaginal latency time to ejaculation.
- Open Access
- 31 March 2026
- Published by Publishing Company VIT-A-POL in Ukrainian Journal of Dermatology, Venerology, Cosmetology
- No. 1,p. 5-17
Treatment of scars resulting from combat wounds and burns: international consensus recommendations based on Ukrainian experience
This work was carried out in order to improve the methods of treatment of patients with post-traumatic and post-burn scars resulting from combat wounds and burns.The paper presents the clinical experience of doctors participating in the Ukrainian Charity project «Neopalymi» («Unburned») — subsidiary of NGO «Ukrainian Volunteer Center», with the support of the Ukrainian Association of Dermatovenerologists and Cosmetologists, in the treatment of patients with post-traumatic and post-burn scars, as well as analyzes the effectiveness of such treatment using generally accepted POSAS scale.As part of this study, protocol recommendations were developed for the treatment of patients with post-traumatic and post-burn scars resulting from combat wounds and burns. Based on the analysis of treatment results using the generally accepted POSAS scale, a fairly high clinical effectiveness of the proposed therapy has been proven.In fact, we can conclude that in the current dramatic times of the war in Ukraine, it was necessary to improve the methods of treating patients with scars that arose after combat wounds and burns. The proposed combination of laser and hardware procedures, as well as the use of injectables and, in particular, polynucleotides, botulinum toxin or polylactic acid, contributed to increasing the therapeutic effectiveness of the treatment of such patients, as well as achieving a more lasting aesthetic effect in them.
- 31 March 2026
- Published by Publishing Company VIT-A-POL in Ukrainian Journal of Dermatology, Venerology, Cosmetology
- No. 1,p. 5-17
Open AccessTreatment of scars resulting from combat wounds and burns: international consensus recommendations based on Ukrainian experience
This work was carried out in order to improve the methods of treatment of patients with post-traumatic and post-burn scars resulting from combat wounds and burns.The paper presents the clinical experience of doctors participating in the Ukrainian Charity project «Neopalymi» («Unburned») — subsidiary of NGO «Ukrainian Volunteer Center», with the support of the Ukrainian Association of Dermatovenerologists and Cosmetologists, in the treatment of patients with post-traumatic and post-burn scars, as well as analyzes the effectiveness of such treatment using generally accepted POSAS scale.As part of this study, protocol recommendations were developed for the treatment of patients with post-traumatic and post-burn scars resulting from combat wounds and burns. Based on the analysis of treatment results using the generally accepted POSAS scale, a fairly high clinical effectiveness of the proposed therapy has been proven.In fact, we can conclude that in the current dramatic times of the war in Ukraine, it was necessary to improve the methods of treating patients with scars that arose after combat wounds and burns. The proposed combination of laser and hardware procedures, as well as the use of injectables and, in particular, polynucleotides, botulinum toxin or polylactic acid, contributed to increasing the therapeutic effectiveness of the treatment of such patients, as well as achieving a more lasting aesthetic effect in them.